.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Recently published research by Sharma A et al. explores how neural states in Parkinson's underpin motor symptom severity. The team analyzed over 1,000 hours of chronic recordings using a Hidden Markov Model. Specifically, these findings support the development of adaptive deep brain stimulation by identifying specific biomarkers for bradykinesia and tremor.
Additionally, researchers identified four distinct neural states during the longitudinal analysis. Consequently, spectral signatures involving subthalamic nucleus (STN) gamma and delta/alpha oscillations predicted worsening bradykinesia. While STN beta activity did not predict bradykinesia, it significantly predicted tremor severity. Furthermore, high STN gamma activity consistently signaled the presence of dyskinesia.
Moreover, the longitudinal analysis demonstrated that these neural states remain stable over several months. Therefore, clinicians might use these specific oscillatory patterns to fine-tune stimulation parameters in real-time. This data-driven approach moves beyond simple beta-band monitoring. Instead, it offers a more comprehensive network-wide analysis of neural dynamics to improve patient outcomes.
Neural states refer to transient patterns of local and interregional oscillatory synchrony within brain circuits. In Parkinson's, these states help predict the severity of specific motor symptoms like tremor or bradykinesia.
By identifying stable neural biomarkers through chronic recordings, this research provides a blueprint for adaptive DBS. This allows for neurostimulation that adjusts automatically based on the patient's current neural state and symptom profile.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Sharma A et al. Dynamic neural states underpin motor symptom severity in Parkinson's disease: a longitudinal analysis of chronic cortico-subthalamic nucleus recordings. EBioMedicine. 2026 May 12. doi: undefined. PMID: 42119302.
Oehrn CR, et al. Neural biomarkers for closed-loop deep brain stimulation in Parkinson’s disease. Nature Communications. 2024.
Little S, Brown P. The Functional Role of Beta Oscillations in Parkinson's Disease. Movement Disorders. 2020.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Researchers identify four neural states that predict motor symptom severity in Parkinson's, providing a blueprint for long-term adaptive neurostimulation....
3 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
